Remove tag data-privacy
article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Benefits of blockchain technology in the pharma supply chain Blockchain technology can address these issues in the pharmaceutical supply chain by providing timely data and increase shared data’s authenticity, integrity , and invariability. This can reduce the willingness for counterfeit and less accurate data, according to the review.

article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

AI is also making waves in how to find and target patient communities as healthcare privacy legislation continues to expand in the United States. Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. to inform HCP engagement strategy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 Things Generative AI Can Do for Commercial Pharma Right Now

PM360

For the life sciences industry, there are questions about the technology’s accuracy, as well as concerns relating to ethics, privacy, and security. If handled properly, LLMs will play an important role in improving data capture and automation, creating efficiencies that will enable us to achieve much more with less.

Pharma 97
article thumbnail

Getting Started With Google Analytics 4 for Healthcare Brands

Healthcare Success

The development and subsequent launch of Google Analytics 4 (GA4) in October 2020 was spurred by a 2018 ruling of Europe’s General Data Protection Regulation (GDPR) , the strictest data privacy and security law in the world. On July 1, 2023, UA will no longer collect or process data. What Is Google Analytics 4?

article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Additionally, both the companies will share CTH-004 pre-clinical and clinical data in future.

article thumbnail

Uncovering the Hidden Gems within Your Datasets

PM360

Data clearly matters in pharma. For the fourth year in a row artificial intelligence (AI) and Big Data ranked as the most impactful technologies in the industry, according to GlobalData’s “The State of the Biopharmaceutical Industry – 2023” report, which includes feedback from 198 companies.

article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Sickle cell disease is an inherited blood disorder that is caused by mutations in the HBB gene, which codes for the oxygen-carrying protein haemoglobin in red blood cells.